Areas for further research
Development of pharmacotherapies based on a basic science understanding of the effects of nicotine and the nicotinic receptor.
Development of more precise behavioural accounts of smoking that suggest more specific behavioural interventions.
Identify elements of behavioural interventions that will enhance effectiveness.
Find ways of enabling healthcare professionals to deliver routine opportunistic advice to stop smoking more often.
Further investigate the combined use of NRT combinations.
Investigate the effectiveness of combining NRT and non-nicotine pharmacotherapies.
Investigate long-term use of pharmacotherapies to prevent relapse to smoking.
Investigate use of NRT in pregnancy.
Investigate long-term use of NRT or other pharmacotherapies as a harm reduction strategy to reduce the amount smoked.
Develop and test interventions for adolescent smokers.
Find ways of improving access to effective interventions.
Identify organizational features of healthcare systems that support the delivery of appropriate interventions.
Investigate optimal sequence of treatments and treatment combinations for repeated attempts to quit.
Investigate treatment of smokers with co-morbidities (psychiatric illness, other chemical dependencies).
Investigate proactive methods to prompt more smokers to make a quit attempt (e.g. phone calls or mailings).
Investigate impact of healthcare reimbursement for smoking cessation intervention.
Top
